Transcat (NASDAQ:TRNS – Get Free Report) had its target price cut by stock analysts at HC Wainwright from $126.00 to $106.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the scientific and technical instruments company’s stock. HC Wainwright’s price objective suggests a potential upside of 38.18% from the company’s previous close.
TRNS has been the topic of a number of other research reports. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Northland Securities reiterated a “market perform” rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday. Craig Hallum raised their price objective on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, StockNews.com raised Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $111.50.
Get Our Latest Stock Report on Transcat
Transcat Stock Up 4.4 %
Transcat (NASDAQ:TRNS – Get Free Report) last issued its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.36% and a net margin of 6.63%. During the same quarter in the previous year, the company earned $0.56 EPS. As a group, sell-side analysts expect that Transcat will post 2.44 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Transcat
Large investors have recently added to or reduced their stakes in the stock. nVerses Capital LLC bought a new stake in shares of Transcat in the third quarter valued at about $60,000. SG Americas Securities LLC bought a new position in Transcat in the fourth quarter worth about $182,000. US Bancorp DE lifted its position in shares of Transcat by 15.6% during the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after buying an additional 209 shares during the last quarter. Captrust Financial Advisors bought a new stake in shares of Transcat in the 3rd quarter valued at about $201,000. Finally, Walleye Capital LLC bought a new position in shares of Transcat during the 3rd quarter worth approximately $216,000. 98.34% of the stock is owned by hedge funds and other institutional investors.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Articles
- Five stocks we like better than Transcat
- How to Calculate Stock Profit
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is a buyback in stocks? A comprehensive guide for investors
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to invest in marijuana stocks in 7 steps
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.